Arkansas 2025 Regular Session

Arkansas House Bill HB1801

Introduced
3/17/25  
Refer
3/17/25  
Report Pass
3/20/25  
Engrossed
3/31/25  
Refer
3/31/25  
Report Pass
4/9/25  
Refer
4/10/25  
Report Pass
4/15/25  
Enrolled
4/16/25  
Chaptered
4/21/25  

Caption

To Authorize An Outsourcing Facility Of Legend Drugs And Controlled Substances That Compounds A Product To Sell The Compounded Product To Certain Entities.

Impact

The implementation of HB1801 is intended to streamline the process through which certain healthcare entities can access compounded medications. By officially designating the parameters under which outsourcing facilities can operate, the bill seeks to regulate and ensure the safety and efficacy of compounded drugs. Compliance with federal Good Manufacturing Practices would be mandated, aligning state regulations with those at the federal level, thus fostering an environment of accountability within the state's pharmaceutical landscape.

Summary

House Bill 1801 aims to authorize registered outsourcing facilities of legend drugs and controlled substances to sell compounded products to specific entities within Arkansas. The bill outlines the criteria for these facilities, emphasizing the requirements for registration with the U.S. Food and Drug Administration and obtaining a permit from the Arkansas State Board of Pharmacy. The primary entities that can receive the compounded products include licensed retail pharmacies, healthcare facilities, and licensed healthcare providers. This advancement is proposed to enhance the availability of compounded medications for Arkansas residents.

Contention

Some points of contention may arise regarding the restrictions placed on the sale of compounded products. The bill specifically forbids outsourcing facilities from selling compounded products to wholesalers or any indirect entities, which may raise concerns about accessibility and flexibility for practitioners who sometimes require compounded medications for specialized patient needs. The delineation between what constitutes an outsourcing facility and other types of pharmaceutical entities will need to be carefully managed to avoid legal ambiguities during enforcement.

Companion Bills

No companion bills found.

Previously Filed As

AR SB274

To Restrict Wholesale Distributors Of Controlled Substances And Legend Drugs From Limiting Or Terminating Sales Of Controlled Substances To Certain Licensed Professionals; And To Declare An Emergency.

AR HB1732

To Require Wholesale Distributors Of Controlled Substances To Educate, Communicate, And Provide Due Process For Licensed Professionals Before Limiting Or Terminating Sales Of Controlled Substances; And To Declare An Emergency.

AR SB502

To Require Wholesale Distributors Of Controlled Substances To Educate, Communicate, And Provide Due Process For Licensed Professionals Before Limiting Or Terminating Sales Of Controlled Substances; And To Declare An Emergency.

AR HB1725

To Inform The Public Of Health Risks Caused By Vapor Products, E-liquid Products, And Alternative Nicotine Products; And To Ensure The Safety Of Arkansas Youth.

AR SB358

To Prohibit Industrial Hemp That Contain Certain Delta Tetrahydrocannabinol Substances; To Include Certain Tetrahydrocannabinol In The List Of Schedule Vi Controlled Substances; And To Declare An Emergency.

AR HB1605

To Provide Regulation Of Hemp-derived Products By The Arkansas Tobacco Control Board.

AR HB1271

To Amend The Prior Authorization Transparency Act; And To Exempt Certain Healthcare Providers That Provide Certain Healthcare Services From Prior Authorization Requirements.

AR HB1456

Creating The Fentanyl Enforcement And Accountability Act Of 2023; Concerning Fentanyl And Other Controlled Substances; To Establish Increased Penalties; And To Declare An Emergency.

AR HB1779

To Amend The Wood Energy Products And Forest Maintenance Income Tax Credit; And To Allow An Income Tax Credit For Wood Energy Products And Forest Maintenance Expansion Projects.

AR SB283

Creating The Fentanyl Enforcement And Accountability Act Of 2023; Concerning Fentanyl And Other Controlled Substances; To Establish Increased Penalties; And To Declare An Emergency.

Similar Bills

CA AB1533

Pharmacy.

OK HB2584

Physicians assistants; Pharmacy Act; prescriptions for controlled dangerous substances; Physician Assistant Act; Committee; members; requirements; Public Health Code; authority for physician assistants to carry out certain functions; prescribing and administering controlled substances; supervision.

LA HB258

Provides for the confidentiality of identifying information of certain persons or entities involved in the execution of a death sentence (EG SEE FISC NOTE GF EX)

OK HB1655

Professions and occupations; Oklahoma Pharmacy Act, modifying definition; authorizing pharmacists to screen and test for certain conditions; codification; effective date.

OK SB931

Practice of pharmacy; allowing pharmacist to test or screen for and initiate drug therapy under certain circumstances; specifying allowed tests; modifying and adding certain definitions. Effective date. Emergency.

OK SB1541

Practice of pharmacy; allowing pharmacist to test for and initiate drug therapy for certain conditions; allowing dispensing of certain products. Effective date. Emergency.

OK HB1655

Professions and occupations; Oklahoma Pharmacy Act, modifying definition; authorizing pharmacists to screen and test for certain conditions; codification; effective date.

OK SB931

Practice of pharmacy; allowing pharmacist to test or screen for and initiate drug therapy under certain circumstances; specifying allowed tests; modifying and adding certain definitions. Effective date. Emergency.